RPF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.272200E-01
Normal-vs-Stage2
6.634400E-01
Normal-vs-Stage3
3.294400E-01
Normal-vs-Stage4
1.646020E-01
Stage1-vs-Stage2
9.899200E-01
Stage1-vs-Stage3
4.207800E-01
Stage1-vs-Stage4
6.610300E-02
Stage2-vs-Stage3
2.907600E-01
Stage2-vs-Stage4
2.615800E-02
Stage3-vs-Stage4
6.345900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.686400E-01
Normal-vs-AfricanAmerican
6.036600E-01
Normal-vs-Asian
9.444600E-01
Caucasian-vs-AfricanAmerican
9.082400E-01
Caucasian-vs-Asian
6.962400E-01
AfricanAmerican-vs-Asian
7.380200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.615800E-01
Normal-vs-Female
9.060400E-01
Male-vs-Female
2.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.057400E-01
Normal-vs-Age(41-60Yrs)
8.667600E-01
Normal-vs-Age(61-80Yrs)
6.854400E-01
Normal-vs-Age(81-100Yrs)
2.011800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.919200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.306600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.686200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.550100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.120450E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.493200E-01
Normal-vs-Daily Drinker
5.486600E-01
Normal-vs-Weekly Drinker
2.765200E-01
Normal-vs-Occasional Drinker
5.435600E-01
Normal-vs-Social Drinker
6.029800E-01
Non Drinker-vs-Daily Drinker
8.071000E-01
Non Drinker-vs-Weekly Drinker
4.584400E-01
Non Drinker-vs-Occasional Drinker
1.718180E-02
Non Drinker-vs-Social Drinker
6.587200E-01
Daily Drinker-vs-Weekly Drinker
3.031800E-01
Daily Drinker-vs-Occasional Drinker
3.890000E-02
Daily Drinker-vs-Social Drinker
8.022400E-01
Weekly Drinker-vs-Occasional Drinker
1.385600E-02
Weekly Drinker-vs-Social Drinker
2.284200E-01
Occasional Drinker-vs-Social Drinker
6.037600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.339800E-01
Normal-vs-Grade 2
8.493200E-01
Normal-vs-Grade 3
8.692000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.593200E-01
Grade 1-vs-Grade 3
8.529600E-01
Grade 1-vs-Grade 4
7.339800E-01
Grade 2-vs-Grade 3
6.354200E-01
Grade 2-vs-Grade 4
8.493200E-01
Grade 3-vs-Grade 4
8.692000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.693200E-01
Normal-vs-NonDiabetic
8.182200E-01
Diabetic-vs-NonDiabetic
1.357790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.553600E-01
Normal-vs-NoPancreatitis
7.595400E-01
Pancreatitis-vs-NoPancreatitis
8.524400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.912600E-01
Normal-vs-N1
6.786200E-01
N0-vs-N1
3.274000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.372400E-01
Normal-vs-TP53-NonMutant
8.951600E-01
TP53-Mutant-vs-TP53-NonMutant
2.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
